Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti-versus Pro-Tumoral Activities

被引:50
作者
Xiang, Zheng [1 ]
Tu, Wenwei [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Lab Translat Immunol, Hong Kong, Hong Kong, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2017年 / 8卷
关键词
V gamma 9V delta 2-T cells; antitumor activity; pro-tumor activity; tumor immunity; tumor immunotherapy; DELTA-T-CELLS; TCR-GAMMA-DELTA; PRENYL PYROPHOSPHATE ANTIGENS; BREAST-CANCER PATIENTS; EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD; ADOPTIVE IMMUNOTHERAPY; IMMUNE-RESPONSES; ZOLEDRONIC ACID; DENDRITIC-CELLS;
D O I
10.3389/fimmu.2017.01041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
V gamma 9V delta 2-T cells are considered as potent effector cells for tumor immunotherapy through directly killing tumor cells and indirectly regulating other innate and adaptive immune cells to establish antitumoral immunity. The antitumoral activity of V gamma 9V delta 2-T cells is governed by a complicated set of activating and inhibitory cell receptors. In addition, cytokine milieu in tumor microenvironment can also induce the pro-tumoral activities and functional plasticity of V gamma 9V delta 2-T cells. Here, we review the anti-versus pro-tumoral activities of V gamma 9V delta 2-T cells and discuss the mechanisms underlying the recognition, activation, differentiation and regulation of V gamma 9V delta 2-T cells in tumor immunosurveillance. The comprehensive understanding of the dual face of V gamma 9V delta 2-T cells in tumor immunology may improve the therapeutic efficacy and clinical outcomes of V gamma 9V delta 2-T cell-based tumor immunotherapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells
    Coscia, Marta
    Vitale, Candida
    Peola, Silvia
    Foglietta, Myriam
    Rigoni, Micol
    Griggio, Valentina
    Castella, Barbara
    Angelini, Daniela
    Chiaretti, Sabina
    Riganti, Chiara
    Guarini, Anna
    Drandi, Daniela
    Ladetto, Marco
    Bosia, Amalia
    Foa, Robin
    Battistini, Luca
    Boccadoro, Mario
    Fournie, Jean-Jacques
    Massaia, Massimo
    BLOOD, 2012, 120 (16) : 3271 - 3279
  • [42] Linking Innate and Adaptive Immunity: Human Vγ9Vδ2 T Cells Enhance CD40 Expression and HMGB-1 Secretion
    Kalyan, Shirin
    Chow, Anthony W.
    MEDIATORS OF INFLAMMATION, 2009, 2009
  • [43] Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model
    Zumwalde, Nicholas A.
    Sharma, Akshat
    Xu, Xuequn
    Ma, Shidong
    Schneider, Christine L.
    Romero-Masters, James C.
    Hudson, Amy W.
    Gendron-Fitzpatrick, Annette
    Kenney, Shannon C.
    Gumperz, Jenny E.
    JCI INSIGHT, 2017, 2 (13):
  • [44] Renal Cell Carcinoma-Infiltrating CD3low Vγ9Vδ1 T Cells Represent Potentially Novel Anti-Tumor Immune Players
    Lee, Hye Won
    Park, Chanho
    Joung, Je-Gun
    Kang, Minyong
    Chung, Yun Shin
    Oh, Won Joon
    Yeom, Seon-Yong
    Park, Woong-Yang
    Kim, Tae Jin
    Seo, Seong Il
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 43 (01) : 226 - 239
  • [45] F1-Adenosine Triphosphatase Displays Properties Characteristic of an Antigen Presentation Molecule for Vγ9Vδ2 T Cells
    Mookerjee-Basu, Jayati
    Vantourout, Pierre
    Martinez, Laurent O.
    Perret, Bertrand
    Collet, Xavier
    Perigaud, Christian
    Peyrottes, Suzanne
    Champagne, Eric
    JOURNAL OF IMMUNOLOGY, 2010, 184 (12) : 6920 - 6928
  • [46] CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy
    Wang, Yizheng
    Wang, Linan
    Seo, Naohiro
    Okumura, Satoshi
    Hayashi, Tae
    Akahori, Yasushi
    Fujiwara, Hiroshi
    Amaishi, Yasunori
    Okamoto, Sachiko
    Mineno, Junichi
    Tanaka, Yoshimasa
    Kato, Takuma
    Shiku, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [47] The Vγ9Vδ2T cell antigen receptor and butyrophilin-3 A1: models of interaction, the possibility of co-evolution, and the case of dendritic epidermalT cells
    Karunakaran, Mohindar M.
    Herrmann, Thomas
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [48] Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production
    Alice, Alejandro F.
    Kramer, Gwen
    Bambina, Shelly
    Bahjat, Keith S.
    Gough, Michael J.
    Crittenden, Marka R.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [49] Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+γδT cells
    Fisher, Jonathan P. H.
    Flutter, Barry
    Wesemann, Florian
    Frosch, Jennifer
    Rossig, Claudia
    Gustafsson, Kenth
    Anderson, John
    ONCOIMMUNOLOGY, 2016, 5 (01):
  • [50] Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vγ9Vδ2 T cells
    Poccia, Fabrizio
    Gioia, Cristiana
    Martini, Federico
    Sacchi, Alessandra
    Piacentini, Paola
    Tempestilli, Massimo
    Agrati, Chiara
    Amendola, Alessandra
    Abdeddaim, Amina
    Vlassi, Chrysoula
    Malkovsky, Miroslav
    D'Offizi, Gianpiero
    AIDS, 2009, 23 (05) : 555 - 565